Global News | World latest News| Trending News
Newswise — In a phase 3 clinical trial, researchers found a new drug combination could be more effective than standard single agent treatment for patients with a type of rare blood cancer called myelofibrosis. The study compared pelabresib and ruxolitinib to standard treatment of ruxolitinib alone. Analysis of the primary endpoint for the study…
Newswise — Barcelona, 25 February 2025 – Myeloid leukaemias are among the most aggressive blood cancers and have low survival rates. Today, leukaemia patients undergo genetic analysis to identify mutations and select the most appropriate treatment. However, even among patients with the same mutation, disease progression and response to therapy can vary significantly. A study…
By John Battaile, M.D. Associate Program Director, Pulmonary and Critical Care Fellowship Program Internal Medicine – Pulmonary and Critical Care Medicine Newswise — I’ve only had one or two significant nosebleeds in my life, after childhood scuffles on the playground. But for patients with hereditary hemorrhagic telangiectasia (HHT), frequent and sometimes intense nosebleeds are a regular occurrence….
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, FEBRUARY 26, 2025 Newswise — MINNEAPOLIS — ALS, or amyotrophic lateral sclerosis, can sometimes be difficult to diagnose or to predict how quickly the disease is likely to progress. A new study helps determine which blood tests are best at identifying and monitoring ALS. The study is…
A blood test to detect the biological age of organs can predict the risk of health conditions years, or even decades later in a finding made by a team led by researchers at University College London in the United Kingdom. Their study, which was published in The Lancet Digital Health, found that faster ageing of…
Newswise — When you hear the condition “blood clot,” your mind may not immediately think of your child being at risk. But Guy Young, MD, Director of the Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles, says he’s seen a recent uptick of patients suffering from blood clots. “Our team treats roughly four…
Newswise — LOS ANGELES (Feb. 6, 2025) — For the fifth year in a row, Cedars-Sinai Cancer patients receiving donor stem cell transplants to treat blood and bone marrow cancer such as acute leukemia experienced better one-year survival rates than those treated at most other U.S. transplant centers. The Blood and Marrow Transplant Program in the Division of…
National Organization for Rare Disorders (NORD®) Issues New Report on Life-Saving Newborn Screening Programs NORD offers comprehensive review on statewide practices related to screening sample retention, provides policy recommendations Newswise — WASHINGTON, Feb. 10, 2025 /PRNewswire/ — The National Organization for Rare Disorders (NORD®) today published a new report on the critical role that leftover newborn screening samples play…
The Covid-19 vaccines were powerfully protective, preventing millions of deaths. But in a small number of people, the shots may have led to a constellation of side effects that includes fatigue, exercise intolerance, brain fog, tinnitus and dizziness, together referred to as “post-vaccination syndrome,” according to a small new study. Some people with this syndrome…
Newswise — New York, NY [February 17, 2025]—Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature of the blood-brain barrier. The findings, in mouse models…
